esophageal cancer
Conditions
Interventions
A:Platinum-based chemotherapy combined with concurrent radiotherapy
B:Taxane-based chemotherapy combined with concurrent radiotherapy
C:Fluoropyrimidine-based chemotherapy combined with concurrent radiotherapy
D:Multiple chemotherapeutic drugs combined with concurrent radiotherapy
Sponsors
Shantou University Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Be willing and able to provide written informed consent/assent for the trial; 2. Patients with previously untreated/ histologically proven squamous cell carcinoma of the esophagus; 3. Aged 18-75 years male and female; 4. Karnofsky Performance Status (KPS) score = 70; 5. Life expectancy = 3 months.
Exclusion criteria
Exclusion criteria: 1. With other malignant tumors; 2. Associated with other serious underlying diseases.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Distant failure-free survival, D-FFS;Locoregional failure-free survival, LR-FFS; | — |
Primary
| Measure | Time frame |
|---|---|
| Complete response rate;Overall Survival(OS);Tissue proteomics;Plasma cytokine chip; | — |
Countries
China
Contacts
Public ContactLi-Yan Xu
Shantou University Medical School
Outcome results
None listed